Archive for December, 2009

Myopia, (nearsightedness) is becoming shockingly more common

12.16.2009

Myopia, also known as nearsightedness, is becoming increasingly common. A study published in this week’s Archives of Ophthalmology shows an alarming rise in the rates of myopia among Americans. Americans aren’t the only ones experiencing this decline in their vision. All across the globe there is an increase in cases of myopia.

eyechart1

Myopia is a common type of refractive error which causes distant objects to appear blurry when not wearing eyeglasses or contact lenses. Close objects, however, are often clear.  Nearsightedness is caused when the eyeball is too long, which causes light to focus in front of the retina. An abnormal shape of the lens or the cornea can cause myopia as well.

While nearsightedness can affect both children and adults, it is most frequently diagnosed in children between the ages of 8 and 12 and can progressively get worse during the teen years. No changes may occur between the ages of 20 and 40 but the condition can worsen with age. Children from nearsighted parents are more likely to develop the condition.

Researchers at the National Eye Institute reported that rates of myopia in people age 12 to 54 increased from 25% in 1971-972 to 41.6% in 1999-2004. People with mild to severe forms of myopia were included in this survey. The dramatic increase in myopia cases points to the need for further research as to what causes the condition and what steps, if any, could be taken to prevent the condition.

The results were based on data gathered from 4,436 black or white Americans from 1971 to 1972 and from 8,339 black or white Americans from 1999 through 2004. The most dramatic rate increase in myopia was noted among black Americans where an increase from 13% in the first survey period to an alarming 35% in the second survey period was noted.

An explanation for some of the increase in cases of myopia could be the improved access to eye screenings and earlier diagnosis of the condition.  Better eye care, however, does not explain all of it. Some fault may lie with the fact that children are spending more time in front of computers and video games and less time outdoors. Such activities could cause the eyes to become geared toward these “near-vision” tasks.

Andrea Schumann
Staff Writer

Discovery of New Inherited Eye Disease

12.14.2009

The discovery of a new inherited eye disease will hopefully  provide a deeper understanding of other common retinal diseases. The new eye disease which affects the macula was discovered by scientists at the University of Iowa.

Bleeding in macular portion of retina

Bleeding in macular portion of retina

Such a discovery is rare. Dr. Vinit Mahajan, the lead author reports that finding a new inherited eye disease affecting the macula is extremely uncommon.

The article detailing the findings is in the November 9 issue of Archives of Ophthalmology. The newly discovered retinal eye disease causes abnormal blood vessels to form in the macula. These malformed blood vessels are inclined to bleed and this leads to both swelling and scars that affect vision. These symptoms are generally connected with another condition known as wet macular degeneration.

Researchers made this discovery when one person in a family came in for care for eye problems. If the doctors had just examined the one patient, macular degeneration would have most likely been the diagnosis. They suspected something was else was going on and they examined 20 extended family members with varying visual problems. The result was the discovery of the new eye disease.

Researchers are hopeful that the discovery of this new macular eye disease will bring about a greater understanding of other eye diseases.

Andrea Schumann
Staff Writer

Taking Aspirin Does Not Decrease Risk of Vision Loss in Elderly

12.09.2009

Aspirin is a cheap over-the-counter-medication that is often hailed for its benefits in reducing the risk of heart attack in patients. However, aspirin does not  decrease the risk of vision loss in elderly patients.

aspirin_web1A study published in the December 2009 issue of Ophthalmology concluded that aspirin had no notable effect on the risk of developing age-related macular degeneration (AMD).

This study took place over several years and was designed to examine whether taking low-dose aspirin on alternate days affects the development of AMD. The study did utilize data from a larger study on aspirin. The study involved 39,876 healthy, female health professionals aged 45 years or older and followed them for an average of 10 years.

While the study findings are only applicable to women, it is noted that AMD is more common in women than in men. Also, there are risks associated with taking daily or alternate-day aspirin and those risks should be weighed against the benefits.

Andrea Schumann
Staff Writer

Patient’s Own Stem Cells May Provide Treatment for AMD

12.07.2009

Stem cells that can be derived from patients may  provide a possible treatment for age-related macular degeneration (AMD). Unlike embryonic stem cells which can cause an immune rejection in the patient, induced stem cells are taken from the patient directly.

rpe_webThe cells in question are known as retinal pigmented epithelial (RPE) cells and they are vital for visual function. Researchers hope that transplanting fresh RPE cells from the patient into the patient’s retina will allow the photoreceptors (rods and cones) in the patient’s eye to stay healthy, which will in turn prevent vision loss.

In a paper published in last week’s PloS One, researchers worked with rats that have a mutation which causes a defect in RPE cells which ultimately leads to vision loss. The researchers discovered that by surgically inserting the stem cell-derived RPE into the rats’ retinas before photoreceptor degeneration, they were able to retain the vision of the rats.

While the scientists note that much more research needs to be done, they are encouraged by the findings of this study and hope that this type of stem-cell based therapy will prove to be an effective treatment for AMD.

Andrea Schumann
Staff Writer

These Great Letters Keep Us Going!

12.04.2009

Each week or two, I get several email responses to my Sight For Life newsletter. (If you’re not already getting this, you can sign up for free at by clicking HERE).

I personally respond to each person. The letters below sure keeps us feeling good about what we’re providing.

Paul Krawitz, M.D., President
Vitamin Science, Inc.

====================

Dear Dr. Krawitz,

My mom has been using your products I got her for her age-related macular…she had a eye dr visit 2 weeks ago….I told him I had gotten her vitamins on your site (Not the ones he recommended from the drug store)…he then said “Oh it doenst matter what you give her! I told him that the ones he suggested could not be taken by mom since she smokes.

Well, he then gave her another test to see how her eyes are doing…and when the girl giving the test looked at the screen and then mom’s old results, he asked another girl to check.

When we got back to the exam room and he looked at the results he said “Ummm…this is unusual…I said what? He said her eyes got better.,..I said better? how much better, 5%, 10%…no 25%!!!!!!!!!!

WOW….BUT BEING A ‘DOCTOR’ WHO DOESNT REALLY BELIEVE IN VITAMINS, HE DIDNT EVEN ASK ME WHAT ARE YOU GIVING HER, TO MAYBE SUGGEST FOR HIS OTHER CLIENTS. NOTHING.

WELL THANKS FOR YOUR HELP…JUST WANTED YOU TO KNOW.

====================

Dear Dr. Krawitz,

Since late November I have been taking VisiVite Gold. I am age 72 and in excellent health. For years I have been taking Rx Omega3 Factors which has helped my joint health (no ACL and no medial meniscus) in particular and now I find is also a plus with eye health as well. I have not been diagnosed with AREDS but my ophthalmologist has indicated that I am experiencing discolorization which could be an forerunner of future problems. After reading you literature, I decided to try VisiVite. The one thing I have noticed since starting the pills has been improved eye moisture. I guess that is good!

====================

Dear Dr.Krawitz

I have been reading all the newsletters you send. hey are very interesting and valuable.First and formost i would like you to know that my mother is making the best outof the information i get because she is actually the one who has the problem . This also includes my grandma who is suffering from macular degenerative eye disease. I shipped the medication i bought to Ethiopia. She has started taking it and will let you know if she has any improvement. We have also informed some friends who have same problem.

Thanks again for your assistance. You are doing a great job

Best Regards

====================

I enjoy your newsletter with the latest studies regarding my condition and don’t want to miss a copy.

====================

Dr. Krawitz, I take VisiVite and Co-Defense regularly for a few years now, and I guess that’s what keeping my problem steady. I also discovered the pill for dry eyes, and find it wonderful. My daughter used to put drops 20-30 times a day. After I gave her the pill for dry eyes, she puts in drops maybe once or twice a day. Thank you for your wonderful products.